Literature DB >> 24865248

Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.

J Moran-Gilad1, A Adler, D Schwartz, S Navon-Venezia, Y Carmeli.   

Abstract

The optimal method for surveillance of carbapenem-resistant Acinetobacter spp. (CRAB) is unknown. A collection of CRAB strains (n = 42), carbapenem-susceptible strains (CSAB), and non-Acinetobacter strains (n = 18) was used to evaluate six laboratory surveillance methods: MacConkey (MAC), MAC + 1 μg/ml imipenem (MAC-IPM), minimal salts agar + 1 % acetate (MSA), MSA with IPM disk (MSA-IPM), CHROMagarKPC, and CHROMagar Acinetobacter with CR102 (CHROMAcineto). CHROMAcineto was 100 % sensitive and specific. CHROMagarKPC and MAC-IPM were highly sensitive (>95 %), but their specificity was substantially hampered by the breakthrough growth of CSAB. MSA was unsuitable for CRAB detection. CHROMAcineto is a promising medium for CRAB detection and warrants further clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24865248     DOI: 10.1007/s10096-014-2159-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  9 in total

1.  Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients.

Authors:  A O Ajao; G Robinson; M S Lee; T D Ranke; R A Venezia; J P Furuno; A D Harris; J K Johnson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

2.  Distribution of Acinetobacter species on skin of healthy humans.

Authors:  J Berlau; H Aucken; H Malnick; T Pitt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1999-03       Impact factor: 3.267

3.  Modifications to CHROMagar Acinetobacter for improved selective growth of multi-drug resistant Acinetobacter baumannii.

Authors:  D W Wareham; N C Gordon
Journal:  J Clin Pathol       Date:  2010-12-03       Impact factor: 3.411

4.  CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.

Authors:  Kevin S Akers; Alice Barsoumian; Miriam L Beckius; Clinton K Murray; Katrin Mende
Journal:  Diagn Microbiol Infect Dis       Date:  2010-06       Impact factor: 2.803

5.  Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.

Authors:  Dror Marchaim; Shiri Navon-Venezia; David Schwartz; Jalal Tarabeia; Iris Fefer; Mitchell J Schwaber; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2007-02-21       Impact factor: 5.948

6.  Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs.

Authors:  Amos Adler; Shiri Navon-Venezia; Jacob Moran-Gilad; Evgeniya Marcos; David Schwartz; Yehuda Carmeli
Journal:  J Clin Microbiol       Date:  2011-04-06       Impact factor: 5.948

7.  Variations of CHROMagar Acinetobacter to detect imipenem-resistant Acinetobacter baumannii-calcoaceticus complex.

Authors:  Alice Barsoumian; Tatjana Calvano; Ana E Markelz; Ryan Cassidy; Clinton K Murray; Miriam L Beckius; Katrin Mende; Kevin S Akers
Journal:  Scand J Infect Dis       Date:  2013-01-15

8.  Evaluation of CHROMagar Acinetobacter for detection of enteric carriage of multidrug-resistant Acinetobacter baumannii in samples from critically ill patients.

Authors:  N C Gordon; D W Wareham
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

Review 9.  Treatment options for multidrug-resistant Acinetobacter species.

Authors:  Jacob Gilad; Yehuda Carmeli
Journal:  Drugs       Date:  2008       Impact factor: 9.546

  9 in total
  1 in total

1.  Detecting carbapenem-resistant Acinetobacter baumannii (CRAB) carriage: Which body site should be cultured?

Authors:  Amir Nutman; Elizabeth Temkin; Jonathan Lellouche; Debby Ben David; David Schwartz; Yehuda Carmeli
Journal:  Infect Control Hosp Epidemiol       Date:  2020-06-19       Impact factor: 3.254

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.